Royal Bank of Canada’s XORTX Therapeutics XRTX Stock Holding History

Royal Bank of Canada’s Portfolio XRTX Stock Details XRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Buy	+732	New	+$1.75K	﹤0.01%	7170
2026 Q1	–	Sell	-818	Closed	-$2K	–	7755
2025 Q4	$2K	Buy	818 +746	+1,036%	+$2.47K	﹤0.01%	6933
2025 Q3	$0	Sell	72 -61	-46%	-$256	﹤0.01%	7582
2025 Q2	$1K	Buy	+133	New	+$628	﹤0.01%	6946
2025 Q1	–	Sell	-299	Closed	-$2K	–	7293
2024 Q4	$2K	Buy	299 +165	+123%	+$1.14K	﹤0.01%	6737
2024 Q3	$1K	Sell	134 -111	-45%	-$950	﹤0.01%	6754
2024 Q2	$2K	Buy	+245	New	+$3.28K	﹤0.01%	6758
2024 Q1	–	Sell	-105	Closed	-$1K	–	7683
2023 Q4	$1K	Buy	105 +104	+10,400%	+$7.67K	﹤0.01%	7003
2023 Q3	$0	Buy	+1	New	+$261	﹤0.01%	7677
2023 Q2	–	Hold	0	–	–	–	7713
2023 Q1	–	Sell	-1	Closed	-$251	–	7558
2022 Q4	$0	Buy	+1	New	+$355	﹤0.01%	7795
2022 Q3	–	Sell	-2	Closed	-$1.13K	–	7938
2022 Q2	$1K	Sell	2 -2	-50%	-$1.27K	﹤0.01%	7227
2022 Q1	$3K	Buy	4 +3	+300%	+$1.98K	﹤0.01%	7412
2021 Q4	$1K	Buy	+1	New	+$1.03K	﹤0.01%	7550

Other funds holding XRTX

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Royal Bank of Canada's XRTX Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in XORTX Therapeutics (XRTX) in Q2 2026: 732 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #7170 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in XRTX as recently as Q4 2025.

Royal Bank of Canada first reported a position in XRTX in Q4 2021 and has held it in 13 quarters since. The position peaked at $3K in Q1 2022. 6 funds tracked by Wall St. Rank hold XRTX as of Q2 2026.

Royal Bank of Canada held 732 shares of XORTX Therapeutics worth $2K as of Q2 2026.
XORTX Therapeutics was a new Royal Bank of Canada position in Q2 2026.
XORTX Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7170 holding.
Royal Bank of Canada first reported a position in XORTX Therapeutics in Q4 2021 and has held it in 13 quarters since.
Royal Bank of Canada's XORTX Therapeutics position peaked at $3K in Q1 2022.
6 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.